220 related articles for article (PubMed ID: 24909809)
1. Effect of TNF-alpha inhibitor treatment on bone mineral density in patients with ankylosing spondylitis: a systematic review and meta-analysis.
Haroon NN; Sriganthan J; Al Ghanim N; Inman RD; Cheung AM
Semin Arthritis Rheum; 2014 Oct; 44(2):155-61. PubMed ID: 24909809
[TBL] [Abstract][Full Text] [Related]
2. The paradoxical effects of TNF inhibitors on bone mineral density and radiographic progression in patients with ankylosing spondylitis.
Kang KY; Ju JH; Park SH; Kim HY
Rheumatology (Oxford); 2013 Apr; 52(4):718-26. PubMed ID: 23275389
[TBL] [Abstract][Full Text] [Related]
3. The change of bone mineral density according to treatment agents in patients with ankylosing spondylitis.
Kang KY; Lee KY; Kwok SK; Ju JH; Park KS; Hong YS; Kim HY; Park SH
Joint Bone Spine; 2011 Mar; 78(2):188-93. PubMed ID: 20621536
[TBL] [Abstract][Full Text] [Related]
4. Etanercept Increases Bone Mineral Density in Ankylosing Spondylitis, but Does Not Prevent Vertebral Fractures: Results of a Prospective Observational Cohort Study.
van der Weijden MA; van Denderen JC; Lems WF; Nurmohamed MT; Dijkmans BA; van der Horst-Bruinsma IE
J Rheumatol; 2016 Apr; 43(4):758-64. PubMed ID: 26879348
[TBL] [Abstract][Full Text] [Related]
5. Increase in bone density in patients with spondyloarthritis during anti-tumor necrosis factor therapy: 6-year followup study.
Durnez A; Paternotte S; Fechtenbaum J; Landewé RB; Dougados M; Roux C; Briot K
J Rheumatol; 2013 Oct; 40(10):1712-8. PubMed ID: 23950191
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor Necrosis Factor Therapy Increased Spine and Femoral Neck Bone Mineral Density of Patients with Active Ankylosing Spondylitis with Low Bone Mineral Density.
Li H; Li Q; Chen X; Ji C; Gu J
J Rheumatol; 2015 Aug; 42(8):1413-7. PubMed ID: 26077412
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of tumor necrosis factor inhibitors and glucocorticoids on bone density in rheumatoid arthritis and ankylosing spondylitis trials.
Siu S; Haraoui B; Bissonnette R; Bessette L; Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Kraft J; Lynde C; Gulliver W; Keeling S; Dutz J; Pope JE
Arthritis Care Res (Hoboken); 2015 May; 67(6):754-64. PubMed ID: 25418272
[TBL] [Abstract][Full Text] [Related]
8. Bone Mineral Density and Fracture Risk in Ankylosing Spondylitis: A Meta-Analysis.
Pray C; Feroz NI; Nigil Haroon N
Calcif Tissue Int; 2017 Aug; 101(2):182-192. PubMed ID: 28421263
[TBL] [Abstract][Full Text] [Related]
9. Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?
Saad CG; Ribeiro AC; Moraes JC; Takayama L; Goncalves CR; Rodrigues MB; de Oliveira RM; Silva CA; Bonfa E; Pereira RM
Arthritis Res Ther; 2012 Oct; 14(5):R216. PubMed ID: 23062122
[TBL] [Abstract][Full Text] [Related]
10. Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss.
Wijbrandts CA; Klaasen R; Dijkgraaf MG; Gerlag DM; van Eck-Smit BL; Tak PP
Ann Rheum Dis; 2009 Mar; 68(3):373-6. PubMed ID: 18408246
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Treatment With TNF-Alpha Inhibitors Improves Bone Mineral Density But Not Vertebral Fracture Progression in Ankylosing Spondylitis.
Beek KJ; Rusman T; van der Weijden MAC; Lems WF; van Denderen JC; Konsta M; Visman I; Nurmohamed MT; van der Horst-Bruinsma IE
J Bone Miner Res; 2019 Jun; 34(6):1041-1048. PubMed ID: 30690799
[TBL] [Abstract][Full Text] [Related]
12. Clinical studies on bone-related outcome and the effect of TNF-α blocking therapy in ankylosing spondylitis.
Arends S; Spoorenberg A; Brouwer E; van der Veer E
Curr Opin Rheumatol; 2014 May; 26(3):259-68. PubMed ID: 24625371
[TBL] [Abstract][Full Text] [Related]
13. Effect of tumor necrosis factor alpha inhibition on bone density and turnover markers in patients with rheumatoid arthritis and spondyloarthropathy.
Barnabe C; Hanley DA
Semin Arthritis Rheum; 2009 Oct; 39(2):116-22. PubMed ID: 18585759
[TBL] [Abstract][Full Text] [Related]
14. Long-term effect of aromatase inhibitors on bone microarchitecture and macroarchitecture in non-osteoporotic postmenopausal women with breast cancer.
Hong AR; Kim JH; Lee KH; Kim TY; Im SA; Kim TY; Moon HG; Han WS; Noh DY; Kim SW; Shin CS
Osteoporos Int; 2017 Apr; 28(4):1413-1422. PubMed ID: 28083668
[TBL] [Abstract][Full Text] [Related]
15. Bone density and fracture risk factors in ankylosing spondylitis: a meta-analysis.
Yan F; Wu L; Lang J; Huang Z
Osteoporos Int; 2024 Jan; 35(1):25-40. PubMed ID: 37814094
[TBL] [Abstract][Full Text] [Related]
16. Which measuring site in ankylosing spondylitis is best to detect bone loss and what predicts the decline: results from a 5-year prospective study.
Deminger A; Klingberg E; Lorentzon M; Geijer M; Göthlin J; Hedberg M; Rehnberg E; Carlsten H; Jacobsson LT; Forsblad-d'Elia H
Arthritis Res Ther; 2017 Dec; 19(1):273. PubMed ID: 29216909
[TBL] [Abstract][Full Text] [Related]
17. Effects of secukinumab on bone mineral density and bone turnover biomarkers in patients with ankylosing spondylitis: 2-year data from a phase 3 study, MEASURE 1.
Braun J; Buehring B; Baraliakos X; Gensler LS; Porter B; Quebe-Fehling E; Haemmerle S
BMC Musculoskelet Disord; 2021 Dec; 22(1):1037. PubMed ID: 34903218
[TBL] [Abstract][Full Text] [Related]
18. Bone mineral density, bone metabolism-related factors, and microRNA-218 are correlated with disease activities in Chinese ankylosing spondylitis patients.
Liu J; Zhao L; Yang X; Liu C; Kong N; Yu Y; Xuan D; Wan W; Xue Y
J Clin Lab Anal; 2022 Feb; 36(2):e24223. PubMed ID: 34984723
[TBL] [Abstract][Full Text] [Related]
19. Relationship of bone mineral density with disease activity and functional ability in patients with ankylosing spondylitis: a cross-sectional study.
Grazio S; Kusić Z; Cvijetić S; Grubišić F; Balenović A; Nemčić T; Matijević-Mikelić V; Punda M; Sieper J
Rheumatol Int; 2012 Sep; 32(9):2801-8. PubMed ID: 21858541
[TBL] [Abstract][Full Text] [Related]
20. Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis.
Visvanathan S; van der Heijde D; Deodhar A; Wagner C; Baker DG; Han J; Braun J
Ann Rheum Dis; 2009 Feb; 68(2):175-82. PubMed ID: 18495735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]